{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:13:44Z","timestamp":1794507224352,"version":"4.9.1"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"am","delay-in-days":182,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["SCR_017767"],"award-info":[{"award-number":["SCR_017767"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA060553"],"award-info":[{"award-number":["P30 CA060553"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["ECCS-2025633"],"award-info":[{"award-number":["ECCS-2025633"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR-2308691"],"award-info":[{"award-number":["DMR-2308691"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21-AI144529"],"award-info":[{"award-number":["R21-AI144529"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["SCR_021192"],"award-info":[{"award-number":["SCR_021192"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NR-49161"],"award-info":[{"award-number":["NR-49161"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["DP2-HL132390"],"award-info":[{"award-number":["DP2-HL132390"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biomaterials.2025.123358","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T02:47:45Z","timestamp":1745290065000},"page":"123358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Efficacy of benznidazole delivery during Chagas disease nanotherapy is dependent on the nanocarrier morphology"],"prefix":"10.1016","volume":"322","author":[{"given":"Debora B.","family":"Scariot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8666-6679","authenticated-orcid":false,"given":"Austeja","family":"Staneviciute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayanne R.B.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6610-4940","authenticated-orcid":false,"given":"Simseok A.","family":"Yuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5304-3459","authenticated-orcid":false,"given":"Yu-Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4829-594X","authenticated-orcid":false,"given":"Swagat","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-5549","authenticated-orcid":false,"given":"Sultan","family":"Almunif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El Hadji","family":"Arona Mbaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Vataru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5869-9844","authenticated-orcid":false,"given":"David M.","family":"Engman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8945-2892","authenticated-orcid":false,"given":"Evan A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.biomaterials.2025.123358_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj1577","article-title":"Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis","volume":"7","author":"Yuk","year":"2021","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123358_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"37","key":"10.1016\/j.biomaterials.2025.123358_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6584","article-title":"Engineering nanoparticles to locally activate T cells in the tumor microenvironment","volume":"4","author":"Wang","year":"2019","journal-title":"Sci. Immunol."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123358_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145523","article-title":"Nanocarrier-enhanced intracellular delivery of benznidazole for treatment of Trypanosoma cruzi infection","volume":"6","author":"Li","year":"2021","journal-title":"JCI Insight"},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123358_bib5","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1056\/NEJM200011093431908","article-title":"Myocarditis","volume":"343","author":"Feldman","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123358_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMp068130","article-title":"Chagas' disease \u2014 can we stop the deaths?","volume":"355","author":"Maguire","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-017-0010-z","article-title":"Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection","volume":"2","author":"Sanchez Alberti","year":"2017","journal-title":"npj Vaccines"},{"key":"10.1016\/j.biomaterials.2025.123358_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1000972","article-title":"Leishmaniasis and Chagas disease: is there hope in nanotechnology to fight neglected tropical diseases?","volume":"12","author":"Scariot","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biomaterials.2025.123358_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.colsurfb.2019.01.039","article-title":"Development and characterization of benznidazole nano-and microparticles: a new tool for pediatric treatment of Chagas disease?","volume":"177","author":"Seremeta","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biomaterials.2025.123358_bib10","article-title":"Encapsulation of benznidazole in nanostructured lipid carriers and increased trypanocidal activity in a resistant Trypanosoma cruzi strain","volume":"59","author":"Silva","year":"2023","journal-title":"Brazil. J. Pharmaceut. Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123358_bib11","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4269\/ajtmh.17-0044","article-title":"Benznidazole nanoformulates: a chance to improve therapeutics for Chagas disease","volume":"97","author":"Vinuesa","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.biomaterials.2025.123358_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112678","article-title":"Improving the oral delivery of benznidazole nanoparticles by optimizing the formulation parameters through a design of experiment and optimization strategy","volume":"217","author":"Arrua","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123358_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004407","article-title":"Use of a chagas urine nanoparticle test (chunap) to correlate with parasitemia levels in T. cruzi\/HIV co-infected patients","volume":"10","author":"Castro-Sesquen","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.biomaterials.2025.123358_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/JEP.S267378","article-title":"Review on experimental treatment strategies against Trypanosoma cruzi","author":"Mazzeti","year":"2021","journal-title":"J. Exp. Pharmacol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123358_bib15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/nnm.14.185","article-title":"Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis","volume":"10","author":"Morilla","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2025.123358_bib16","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.2147\/IJN.S206109","article-title":"Advances in nanocarriers as drug delivery systems in Chagas disease","author":"Quijia Quezada","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123358_bib17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3390\/ph16081163","article-title":"Use of nanocarriers containing antitrypanosomal drugs for the treatment of Chagas disease","volume":"16","author":"Paiva","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123358_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers: the STOP-CHAGAS trial","volume":"69","author":"Morillo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biomaterials.2025.123358_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1233253","article-title":"Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities","volume":"14","author":"Porta","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biomaterials.2025.123358_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2020.102248","article-title":"Dual chemotherapy with benznidazole at suboptimal dose plus curcumin nanoparticles mitigates Trypanosoma cruzi-elicited chronic cardiomyopathy","volume":"81","author":"Hern\u00e1ndez","year":"2021","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.biomaterials.2025.123358_bib21","article-title":"Exploration of innovative drug repurposing strategies for combating human protozoan diseases: advances, challenges, and opportunities","author":"Hu","year":"2024","journal-title":"J. Pharmaceut. Anal."},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123358_bib22","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1017\/S0031182022001081","article-title":"Monotherapy and combination chemotherapy for Chagas disease treatment: a systematic review of clinical efficacy and safety based on randomized controlled trials","volume":"149","author":"Nogueira","year":"2022","journal-title":"Parasitology"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123358_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/13543784.2024.2349289","article-title":"Drugs in preclinical and early clinical development for the treatment of chagas' s disease: the current status","volume":"33","author":"Torchelsen","year":"2024","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123358_bib24","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1007\/s12274-022-5267-5","article-title":"Use of stimulatory responsive soft nanoparticles for intracellular drug delivery","volume":"16","author":"Hughes","year":"2023","journal-title":"Nano Res."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123358_bib25","doi-asserted-by":"crossref","first-page":"11290","DOI":"10.1021\/acsnano.6b06451","article-title":"Tailoring nanostructure morphology for enhanced targeting of dendritic cells in atherosclerosis","volume":"10","author":"Yi","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123358_bib26","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1007\/s12274-018-2069-x","article-title":"Polymersomes scalably fabricated via flash nanoprecipitation are non-toxic in non-human primates and associate with leukocytes in the spleen and kidney following intravenous administration","volume":"11","author":"Allen","year":"2018","journal-title":"Nano Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123358_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1039\/C8NH00300A","article-title":"On the advancement of polymeric bicontinuous nanospheres toward biomedical applications","volume":"4","author":"Allen","year":"2019","journal-title":"Nanoscale Horiz."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123358_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nmat1081","article-title":"Oxidation-responsive polymeric vesicles","volume":"3","author":"Napoli","year":"2004","journal-title":"Nat. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123358_bib29","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaci.2016.12.985","article-title":"Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses","volume":"140","author":"Dowling","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123358_bib30","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2217\/nnm-2018-0052","article-title":"Influences of nanocarrier morphology on therapeutic immunomodulation","volume":"13","author":"Frey","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2025.123358_bib31","unstructured":"G. Ferri, M.M. Edreira, All Roads Lead to Cytosol: Trypanosoma cruzi Multi-Strategic Approach to Invasion, (2235-2988 (Electronic))."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123358_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.171.2.401","article-title":"The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments","volume":"171","author":"Ley","year":"1990","journal-title":"J. Exp. Med."},{"issue":"26","key":"10.1016\/j.biomaterials.2025.123358_bib33","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1016\/j.biomaterials.2012.04.060","article-title":"Dendritic cell activation and T cell priming with adjuvant-and antigen-loaded oxidation-sensitive polymersomes","volume":"33","author":"Scott","year":"2012","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123358_bib34","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1021\/nn302122h","article-title":"Precision intracellular delivery based on optofluidic polymersome rupture","volume":"6","author":"Vasdekis","year":"2012","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123358_bib35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1039\/D0NH00679C","article-title":"Enhancing subcutaneous injection and target tissue accumulation of nanoparticles via co-administration with macropinocytosis inhibitory nanoparticles (MiNP)","volume":"6","author":"Stack","year":"2021","journal-title":"Nanoscale Horiz."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/la0478043","article-title":"Oxidation-sensitive polymeric nanoparticles","volume":"21","author":"Rehor","year":"2005","journal-title":"Langmuir"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123358_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1039\/C8BM01224E","article-title":"Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis","volume":"7","author":"Allen","year":"2019","journal-title":"Biomater. Sci."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123358_bib38","article-title":"Pi\u2010stacking enhances stability, scalability of formation, control over flexibility, and circulation time of polymeric filamentous nanocarriers","volume":"1","author":"Li","year":"2021","journal-title":"Advan. Nanobiomed Res."},{"key":"10.1016\/j.biomaterials.2025.123358_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109769","article-title":"Milestones in the development and implementation of FRET-based sensors of intracellular signals: a biological perspective of the history of FRET","volume":"75","author":"Deal","year":"2020","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123358_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000419","article-title":"Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in Chagas disease patients","volume":"3","author":"Duffy","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123358_bib41","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","article-title":"Revisiting cardiac cellular composition","volume":"118","author":"Pinto","year":"2016","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123358_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123358_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","article-title":"Dynamic light scattering: a practical guide and applications in biomedical sciences","volume":"8","author":"Stetefeld","year":"2016","journal-title":"Biophys. Rev."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123358_bib44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1208\/s12249-022-02303-y","article-title":"Current status and challenges of analytical methods for evaluation of size and surface modification of nanoparticle-based drug formulations","volume":"23","author":"Takechi-Haraya","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biomaterials.2025.123358_bib45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential\u2013what they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123358_bib46","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1021\/acsomega.8b03562","article-title":"A protocol to characterize peptide-based drug delivery systems for miRNAs","volume":"4","author":"Schachner-Nedherer","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.biomaterials.2025.123358_bib47","series-title":"Zeta Potential Measurement, Characterization of Nanoparticles Intended for Drug Delivery","first-page":"63","author":"Clogston","year":"2011"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123358_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41565-021-01048-2","article-title":"Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability","volume":"17","author":"Burke","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48492-9","article-title":"All-trans retinoic acid and dexamethasone regulate phagocytosis-related gene expression and enhance dead cell uptake in C2C12 myoblast cells","volume":"13","author":"Adil Ali","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1083\/jcb.201401137","article-title":"Dynamin and endocytosis are required for the fusion of osteoclasts and myoblasts","volume":"207","author":"Shin","year":"2014","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.biomaterials.2025.123358_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00918","article-title":"An animal model of acute and chronic Chagas disease with the reticulotropic Y strain of Trypanosoma cruzi that depicts the multifunctionality and dysfunctionality of T cells","volume":"10","author":"Mateus","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123358_bib52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2307\/3279787","article-title":"Tissue tropism of different Trypanosoma cruzi strains","volume":"64","author":"Melo","year":"1978","journal-title":"J. Parasitol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123358_bib53","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/mp7001297","article-title":"PEG-b-PPS diblock copolymer aggregates for hydrophobic drug solubilization and release: cyclosporin A as an example","volume":"5","author":"Velluto","year":"2008","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123358_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02410-16","article-title":"Pharmacokinetics and tissue distribution of benznidazole after oral administration in mice","volume":"61","author":"Perin","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123358_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.01383-20","article-title":"Pharmacokinetics of benznidazole in experimental chronic chagas disease using the Swiss Mouse\u2013Berenice-78 Trypanosoma cruzi strain model","volume":"65","author":"de Jesus","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2025.123358_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2019.105080","article-title":"Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: a review","volume":"198","author":"Arr\u00faa","year":"2019","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib57","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1080\/10717544.2019.1692968","article-title":"Nanoparticles for antiparasitic drug delivery","volume":"26","author":"Sun","year":"2019","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123358_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100639","article-title":"Liposomes and extracellular vesicles as drug delivery systems: a comparison of composition, pharmacokinetics, and functionalization","volume":"11","author":"van der Koog","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2025.123358_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104070","article-title":"Endolysosomal trapping of therapeutics and endosomal escape strategies","author":"Ahmad","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123358_bib61","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/mmi.14763","article-title":"Unraveling the antitrypanosomal mechanism of benznidazole and related 2\u2010nitroimidazoles: from prodrug activation to DNA damage","volume":"116","author":"Dattani","year":"2021","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13071-023-05775-4","article-title":"Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations","volume":"16","author":"Lima","year":"2023","journal-title":"Parasites Vectors"},{"issue":"22","key":"10.1016\/j.biomaterials.2025.123358_bib63","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.3390\/molecules28227461","article-title":"Anti-trypanosoma cruzi activity, mutagenicity, hepatocytotoxicity and nitroreductase enzyme evaluation of 3-nitrotriazole, 2-nitroimidazole and triazole derivatives","volume":"28","author":"Menozzi","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2025.123358_bib64","first-page":"504","volume":"vol. 112","author":"Montenegro","year":"2017"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123358_bib65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/em.21839","article-title":"Unveiling benznidazole's mechanism of action through overexpression of DNA repair proteins in Trypanosoma cruzi","volume":"55","author":"Rajao","year":"2014","journal-title":"Environ. Mol. Mutagen."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123358_bib66","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jac\/dks478","article-title":"Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection","volume":"68","author":"Gulin","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123358_bib67","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1001\/jama.298.18.2171","article-title":"Evaluation and treatment of Chagas disease in the United States: a systematic review","volume":"298","author":"Bern","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25056-x","article-title":"Effect of benznidazole on cerebral microcirculation during acute Trypanosoma cruzi infection in mice","volume":"12","author":"Gonzaga","year":"2022","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123358_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022155","article-title":"Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo","volume":"6","author":"Batista","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib70","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01852-21","article-title":"Experimental combination therapy with amiodarone and low-dose benznidazole in a mouse model of Trypanosoma cruzi acute infection","volume":"10","author":"Barbosa","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123358_bib71","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-3024.1995.tb00999.x","article-title":"The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti\u2010TNF\u2010a, but not by anti\u2010IL\u20106 or anti\u2010IFN\u20107 antibodies","volume":"17","author":"Truyens","year":"1995","journal-title":"Parasite Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123358_bib72","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00430-018-0572-z","article-title":"Immune response triggered by Trypanosoma cruzi infection strikes adipose tissue homeostasis altering lipid storage, enzyme profile and adipokine expression","volume":"208","author":"Gonz\u00e1lez","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123358_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008726","article-title":"Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole","volume":"14","author":"Calvet","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"10115","key":"10.1016\/j.biomaterials.2025.123358_bib74","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2025.123358_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116742","article-title":"Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection","volume":"175","author":"Barbosa","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123358_bib76","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/pathogens10091074","article-title":"The liver and the hepatic immune response in Trypanosoma cruzi infection, a historical and updated view","volume":"10","author":"Vacani-Martins","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.biomaterials.2025.123358_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105912","article-title":"Improved efficacy and safety of low doses of benznidazole-loaded multiparticulate delivery systems in experimental Chagas disease therapy","volume":"164","author":"Garc\u00eda","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib78","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1038\/s41598-017-08086-8","article-title":"A multi-parametric analysis of Trypanosoma cruzi infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses","volume":"7","author":"Santi-Rocca","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2025.123358_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.868574","article-title":"In the acute phase of Trypanosoma cruzi infection, liver lymphoid and myeloid cells display an ambiguous phenotype combining pro-and anti-inflammatory markers","volume":"13","author":"de Lima Pereira dos Santos","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123358_bib80","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3389\/fimmu.2018.01929","article-title":"The unsolved jigsaw puzzle of the immune response in Chagas disease","volume":"9","author":"Acevedo","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123358_bib81","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41581-022-00558-z","article-title":"Kidney complications of parasitic diseases","volume":"18","author":"Daher","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123358_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071772","article-title":"Influence of parasite load on renal function in mice acutely infected with Trypanosoma cruzi","volume":"8","author":"Lemos","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123358_bib83","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1039\/D0NA00716A","article-title":"Kinetics of nanoparticle uptake into and distribution in human cells","volume":"3","author":"\u00c5berg","year":"2021","journal-title":"Nanoscale Adv."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123358_bib84","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1073\/pnas.0707046105","article-title":"Release of hydrophobic molecules from polymer micelles into cell membranes revealed by F\u00f6rster resonance energy transfer imaging","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2025.123358_bib85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pacs.2017.04.002","article-title":"Detection of intramyocardially injected DiR-labeled mesenchymal stem cells by optical and optoacoustic tomography","volume":"6","author":"Berninger","year":"2017","journal-title":"Photoacoustics"},{"issue":"5417","key":"10.1016\/j.biomaterials.2025.123358_bib86","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.284.5417.1143","article-title":"Polymersomes: tough vesicles made from diblock copolymers","volume":"284","author":"Discher","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123358_bib87","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0168-3659(03)00201-3","article-title":"Polymer vesicles in vivo: correlations with PEG molecular weight","volume":"90","author":"Photos","year":"2003","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123358_bib88","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nmat2512","article-title":"Spotted vesicles, striped micelles and Janus assemblies induced by ligand binding","volume":"8","author":"Christian","year":"2009","journal-title":"Nat. Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123358_bib89","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1021\/la0531998","article-title":"Assessment of the integrity of poly (caprolactone)-b-poly (ethylene oxide) micelles under biological conditions: a fluorogenic-based approach","volume":"22","author":"Savi\u0107","year":"2006","journal-title":"Langmuir"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123358_bib90","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/bm400234c","article-title":"\u03a0\u2013\u03a0 stacking increases the stability and loading capacity of thermosensitive polymeric micelles for chemotherapeutic drugs","volume":"14","author":"Shi","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2025.123358_bib91","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1007\/s12274-018-2152-3","article-title":"Strategies to improve micelle stability for drug delivery","volume":"11","author":"Lu","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.biomaterials.2025.123358_bib92","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","article-title":"Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions","volume":"332","author":"Ghezzi","year":"2021","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123358_bib93","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1369-7021(12)70195-5","article-title":"Intracellular drug release nanosystems","volume":"15","author":"Meng","year":"2012","journal-title":"Mater. Today"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123358_bib94","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cossms.2012.09.001","article-title":"Multifunctional nanocarriers and intracellular drug delivery","volume":"16","author":"Sawant","year":"2012","journal-title":"Curr. Opin. Solid State Mater. Sci."},{"key":"10.1016\/j.biomaterials.2025.123358_bib95","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2022.06.048","article-title":"FRET as the tool for in vivo nanomedicine tracking","volume":"349","author":"Kaeokhamloed","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123358_bib96","first-page":"2576","article-title":"F\u00f6rster resonance energy transfer-based stability assessment of PLGA nanoparticles in vitro and in vivo","author":"Swider","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.biomaterials.2025.123358_bib97","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jconrel.2023.07.026","article-title":"FRET-based analysis on the structural stability of polymeric micelles: another key attribute beyond PEG coverage and particle size affecting the blood clearance","volume":"360","author":"Guo","year":"2023","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123358_bib98","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","article-title":"PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect","volume":"63","author":"Acharya","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123358_bib99","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2014.05.029","article-title":"Sustained-release from nanocarriers: a review","volume":"193","author":"Natarajan","year":"2014","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123358_bib100","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/pharmaceutics13060770","article-title":"Degradation of drug delivery nanocarriers and payload release: a review of physical methods for tracing nanocarrier biological fate","volume":"13","author":"Perrigue","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib101","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41467-020-20886-7","article-title":"Surface chemistry-mediated modulation of adsorbed albumin folding state specifies nanocarrier clearance by distinct macrophage subsets","volume":"12","author":"Vincent","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib102","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41467-018-03001-9","article-title":"Sustained micellar delivery via inducible transitions in nanostructure morphology","volume":"9","author":"Karabin","year":"2018","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123358_bib103","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"issue":"9\u201310","key":"10.1016\/j.biomaterials.2025.123358_bib104","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/smll.201201390","article-title":"Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking","volume":"9","author":"Duan","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123358_bib105","series-title":"Nanotechnology and Nanomaterials in the Treatment of life-threatening Diseases","first-page":"53","article-title":"Chapter 2 - nano-based drug delivery and diagnostic systems","author":"Kumar","year":"2014"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123358_bib106","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2025.123358_bib107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2020.07.014","article-title":"Fast processes of nanoparticle blood clearance: comprehensive study","volume":"326","author":"Zelepukin","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123358_bib108","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jconrel.2022.12.028","article-title":"Applications and challenges of ultra-small particle size nanoparticles in tumor therapy","volume":"353","author":"Xu","year":"2023","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123358_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202100062","article-title":"The combination of morphology and surface chemistry defines the immunological identity of nanocarriers in human blood","volume":"4","author":"Vincent","year":"2021","journal-title":"Adv. Therapeut."},{"key":"10.1016\/j.biomaterials.2025.123358_bib110","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","article-title":"Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery","volume":"30","author":"Kulkarni","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2025.123358_bib111","series-title":"Goldman's Cecil Medicine","first-page":"124","article-title":"28 - principles of drug therapy","author":"Diasio","year":"2012"},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123358_bib112","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1021\/acs.chemrev.8b00199","article-title":"Block copolymer micelles in nanomedicine applications","volume":"118","author":"Cabral","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2025.123358_bib113","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.02.016","article-title":"Polymeric micelles in cancer therapy: state of the art","volume":"332","author":"Ghosh","year":"2021","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123358_bib114","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1021\/acs.molpharmaceut.3c00598","article-title":"Role of polymeric micelles in ocular drug delivery: an overview of decades of research","volume":"20","author":"Binkhathlan","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123358_bib115","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.3c00528","article-title":"Progress in treatment and diagnostics of infectious disease with polymers","author":"Patra","year":"2024","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib116","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ahj.2008.04.001","article-title":"Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)","volume":"156","author":"Marin-Neto","year":"2008","journal-title":"Am. Heart J."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123358_bib117","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrcardio.2012.109","article-title":"Diagnosis and management of Chagas disease and cardiomyopathy","volume":"9","author":"Ribeiro","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biomaterials.2025.123358_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10050505","article-title":"Chagas cardiomyopathy: from roma\u00f1a sign to heart failure and sudden cardiac death","author":"Pino-Mar\u00edn","year":"2021","journal-title":"Pathogens"},{"issue":"42","key":"10.1016\/j.biomaterials.2025.123358_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201904399","article-title":"Surface engineered polymersomes for enhanced modulation of dendritic cells during cardiovascular immunotherapy","volume":"29","author":"Yi","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10741-018-9720-1","article-title":"Biomarkers for the identification of cardiac fibroblast and myofibroblast cells","volume":"24","author":"Tarbit","year":"2019","journal-title":"Heart Fail. Rev."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123358_bib121","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019338","article-title":"Complex relationship between cardiac fibroblasts and cardiomyocytes in health and disease","volume":"10","author":"Hall","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biomaterials.2025.123358_bib122","unstructured":"K. Guimar\u00e3es-Pinto, D.O. Nascimento, A. Corr\u00eaa-Ferreira, A. Morrot, C.G. Freire-de-Lima, M.F. Lopes, G.A. DosReis, A.A. Filardy, Trypanosoma cruzi Infection Induces Cellular Stress Response and Senescence-like Phenotype in Murine Fibroblasts, (1664-3224 (Print))."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123358_bib123","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/CIRCRESAHA.124.324507","article-title":"Arrhythmogenic manifestations of chagas disease: perspectives from the bench to bedside","volume":"134","author":"Roman-Campos","year":"2024","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123358_bib124","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2353\/ajpath.2007.060643","article-title":"Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection","volume":"171","author":"de Oliveira","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123358_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002034","article-title":"Trypanosoma cruzi infection and endothelin-1 cooperatively activate pathogenic inflammatory pathways in cardiomyocytes","volume":"7","author":"Corral","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.biomaterials.2025.123358_bib126","doi-asserted-by":"crossref","unstructured":"F.S. Machado, W.O. Dutra, L. Esper, K.J. Gollob, M.M. Teixeira, S.M. Factor, L.M. Weiss, F. Nagajyothi, H.B. Tanowitz, N.J. Garg, Current Understanding of Immunity to Trypanosoma cruzi Infection and Pathogenesis of Chagas Disease, Springer, pp. 753-770.","DOI":"10.1007\/s00281-012-0351-7"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225002777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225002777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:56:24Z","timestamp":1762242984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225002777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":126,"alternative-id":["S0142961225002777"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123358","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of benznidazole delivery during Chagas disease nanotherapy is dependent on the nanocarrier morphology","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123358"}}